How mNGS Testing Delivers Unmatched Pathogen Detection in Infectious Diseases
Delve Bio found that mNGS identified more pathogens from cerebrospinal fluid samples than all conventional diagnostic methods combined.
Read MorePosted by Andy Lundin | Nov 21, 2024 | Molecular Diagnostics |
Delve Bio found that mNGS identified more pathogens from cerebrospinal fluid samples than all conventional diagnostic methods combined.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Disease States |
Discovering mutations in the FLVCR1 gene, provided a genetic diagnosis for 30 individuals with previously undiagnosed conditions.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lab Automation |
Artificial Intelligence enables development of new diagnostic and prognostic models, supporting the move toward personalized medicine.
Read MorePosted by Andy Lundin | Nov 14, 2024 | Molecular Diagnostics |
A research team developed a new method for detecting low-abundance proteins in plasma, enhancing early disease detection.
Read MorePosted by Andy Lundin | Nov 14, 2024 | Emerging & Zoonotic Diseases, Molecular Diagnostics |
Alveo Technologies secured a CDC agreement to develop a test for detecting and differentiating between Influenza A, B, and A/H5.
Read More